retatrutide fatty liver study vs Mounjaro: triple agonist versus dual agonist compared Triple hormone receptor agonist retatrutide

Heres how it works: you start by completing a medical intake form to see if you're a candidate

For the experimental group, participants had to be on a maintenance dose (at least 4 weeks, Supplemental Table 1) of a GLP-1RA medication for weight loss

"Tirzepatide Once Weekly for the Treatment of Obesity." NEJM 2022 Frequently Asked Questions TRIUMPH-1 (May 21, 2026) showed retatrutide achieved 28.3% average weight loss at 80 weeks in 2,339 adults without diabetes

Abell SK, Boyle JA, de Courten B et al (2016) Contemporary type 1 diabetes pregnancy outcomes: impact of obesity and glycaemic control

It is important to recognize that clinical trials may have limited power to detect small increases in risk for specific rare cancer types, and longer-term observational studies will continue to provide important safety information

Beyond clinical evidence, the recently released consumer perception study explores the perceived benefits of BC30 in a real-world context, further reinforcing its potential to support digestive health and enhance overall quality of life, making it a probiotic GLP-1 users can feel confident about